Neomend
Biomedical device company engaged in the development and commercialization of surgical wound healing products.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD191m (Public information from Oct 2012)
Irvine California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | Series B | |
$6.0m | Series C | ||
N/A | $2.7m | Debt | |
N/A | $3.0m | Debt | |
$30.0m | Series D | ||
$20.0m | Series D | ||
$140m Valuation: $140m | Acquisition | ||
Total Funding | CAD76.4m |